PF-06823859
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for PF-06823859, covering 2017-11-17 to 2026-08-11. Get the full timeline:
Most recent: Clinical Trial Results: A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms. [Phase 2]